Trials / Conditions / Macular Telangiectasia Type 2
Macular Telangiectasia Type 2
5 registered clinical trials studyying Macular Telangiectasia Type 2.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | A Study to Determine the Safety and Efficacy of NT-501 With MHFM NCT06397131 | Neurotech Pharmaceuticals | Phase 3 |
| Unknown | Serine and Fenofibrate Study in Patients With MacTel Type 2 NCT04907084 | The Lowy Medical Research Institute Limited | Phase 2 |
| Completed | Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2 NCT04729972 | Neurotech Pharmaceuticals | Phase 2 |
| Completed | A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol B NCT03319849 | Neurotech Pharmaceuticals | Phase 3 |
| Completed | A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel NCT01949324 | Neurotech Pharmaceuticals | Phase 2 |